Abstract
Objective
Observational data, though sparse and based on small studies with limited ability to control for known breast cancer risk factors, support a lower risk of breast cancer in blind women compared to sighted women. Mechanisms influenced by ocular light perception, such as melatonin or circadian synchronization, are thought to account for this lower risk.
Methods
To evaluate whether blind women with no perception of light (NPL) have a lower prevalence of breast cancer compared to blind women with light perception (LP), we surveyed a cohort of 1,392 blind women living in North America (66 breast cancer cases).
Results
In multivariate-logistic regression models controlling for breast cancer risk factors, women with NPL had a significantly lower prevalence of breast cancer than women with LP (odds ratio, 0.43; 95% confidence interval, 0.21–0.85). We observed little difference in these associations when restricting to postmenopausal women, non-shift workers or when excluding women diagnosed with breast cancer within 2 or 4 years of onset of blindness. Blind women with NPL appear to have a lower risk of breast cancer, compared to blind women with LP. More research is needed to elucidate the impact of LP on circadian coordination and melatonin production in the blind and how these factors may relate to breast cancer risk.
References
Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208–210
Pukkala E, Verkasalo PK, Ojamo M, Rudanko S-L (1999) Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 10:13–20
Feychting M, Österland B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494
Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397–399
Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko S-L (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80(9):1459–1460
Pukkala E, Ojamo M, Sirkka-Liisa R, Stevens RG, Verkasalo P (2006) Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control 17:573–576
Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW (2009) Effect of light perception on menarche in blind women. Ophthalmic Epidemiol 16(4):243–258
Schernhammer ES, Kroenke CH, Laden F, Hankinson SE (2006) Night work and risk of breast cancer. Epidemiology 17(1):108–111
Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93(20):1557–1562
Pukkala E, Auvinen A, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants, 1967–1992. BMJ 311:649–652
Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8(12):1065–1066
Coleman MP, Reiter RJ (1992) Breast cancer, blindness and melatonin. Eur J Cancer 28(2–3):501–503
Stevens RG, Blask DE, Brainard GC et al (2007) Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 115(9):1357–1362
Brainard GC, Hanifin JP (2005) Photons, clocks, and consciousness. J Biol Rhythms 20(4):314–325
Arendt J (2005) Melatonin: characteristics, concerns, and prospects. J Biol Rhythms 20(4):291–303
Gooley JJ, Lu J, Chou TC, Scammell TE, Saper CB (2001) Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci 4(21):1165
Lockley SW, Arendt J, Skene DJ (2007) Visual impairment and circadian rhythm disorders. Dialogues Clin Neurosci 9(3):301–314
Blask DE, Brainard GC, Dauchy RT et al (2005) Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65(23):11174–11184
Filipski E, Delaunay F, King VM et al (2004) Effects of chronic jet lag on tumor progression in mice. Cancer Res 64(21):7879–7885
Zaidi FH, Hull JT, Peirson SN et al (2007) Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol 17(24):2122–2128
Acknowledgments
The authors thank Dr. Elizabeth Klerman, Professor Debra J. Skene, Dr. Benita Middleton, Emeritus Professor Josephine Arendt, Eve Silver, Amy Ruell, and Joseph Hull for assistance with this project. The authors also wish to thank the students who assisted with data collection, including Kathleen Maguire, Emily McCoy, Rebecca Steinberg, Jennifer Markham, Kai Romero, Yunxue Xu, Michael Steinhaus, Inés Pacheco, Grace Kim, Folasade Odenyi, Naila Ramji, Anna Rosenblum, Emma Prokic, Erica Bloom, Natasha Makengo, Ashley Pawlisz, Nicholas Moser, Alana Vivolo, Jessica Giordano, Marissa Sheldon, Tomoko Okada, Liwei Fan, Kristoff Nelson, Kevin Sun, and Jane Flynn. The authors also wish to thank several organizations who donated time and effort to assist with this project, including the American Council of the Blind, the Bay State Council for the Blind, the Massachusetts Commission for the Blind, the Canadian National Institute of the Blind, the National Braille Press, the National Federation of the Blind, the Perkins Braille and Talking Book Library, radio reading services nationwide, and Ripco. Finally, the authors would like to thank Velir Studios for development of the study website. This work was supported by a Department of Defense Breast Cancer Research Program Idea Award (BC030928, #W81XWH-04-1-0553 to SWL) and a predoctoral fellowship from the Harvard Medical School Division of Sleep Medicine Training Program in Sleep, Circadian, and Respiratory Neurobiology (Grant HL07901-11 to EEE).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Flynn-Evans, E.E., Stevens, R.G., Tabandeh, H. et al. Total visual blindness is protective against breast cancer. Cancer Causes Control 20, 1753–1756 (2009). https://doi.org/10.1007/s10552-009-9405-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-009-9405-0